Last reviewed · How we verify

ODSH at 0.125 mg/kg/h — Competitive Intelligence Brief

ODSH at 0.125 mg/kg/h (ODSH at 0.125 mg/kg/h) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Protein sequestrant; modified polysaccharide; orphan therapeutic. Area: Immunology.

discontinued Protein sequestrant; modified polysaccharide; orphan therapeutic Intestinal lymphatic proteins (albumin, immunoglobulins); mechanism targets protein loss pathway in enteropathy Immunology Small molecule Live · refreshed every 30 min

Target snapshot

ODSH at 0.125 mg/kg/h (ODSH at 0.125 mg/kg/h) — Jazz Pharmaceuticals. ODSH is a modified chitosan polymer that binds intestinal lymphatic proteins to reduce protein loss in enteropathy.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ODSH at 0.125 mg/kg/h TARGET ODSH at 0.125 mg/kg/h Jazz Pharmaceuticals discontinued Protein sequestrant; modified polysaccharide; orphan therapeutic Intestinal lymphatic proteins (albumin, immunoglobulins); mechanism targets protein loss pathway in enteropathy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Protein sequestrant; modified polysaccharide; orphan therapeutic class)

  1. Jazz Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ODSH at 0.125 mg/kg/h — Competitive Intelligence Brief. https://druglandscape.com/ci/odsh-at-0-125-mg-kg-h. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: